Evidence map›Paper›PMID 27066836›Full record

ArticleNature communications2016

A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation.

Nathan Orr, Rima Arnaout, Lorne J Gula, Danna A Spears, Peter Leong-Sit, Qiuju Li, Wadea Tarhuni, Sven Reischauer, Vijay S Chauhan, Matthew Borkovich and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 2 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 2 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Plasma Proteomics Reveals Dysregulated Pathways Across the SpectrumCirculation. Genomic and precision medicine · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  18. Article
  19. Genetics, transcriptomics, metagenomics, and metabolomics in the pathogenesis and prediction of atrial fibrillation.European heart journal supplements : journal of the European Society of Cardiology · 2024
    Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Nathan OrrToronto General Research Institute, University Health Network, Toronto, Ontario, Canada M5G 2C4.
Rima ArnaoutDepartment of Medicine, Cardiovascular Research Institute and Division of Cardiology, University of California San Francisco, San Francisco, California 94158, USA.
Lorne J GulaDivision of Cardiology, University Hospital, Western University, London, Ontario, Canada N6G 2V4.
Danna A SpearsDivision of Cardiology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada M5G 2C4.
Peter Leong-SitDivision of Cardiology, University Hospital, Western University, London, Ontario, Canada N6G 2V4.
Qiuju LiToronto General Research Institute, University Health Network, Toronto, Ontario, Canada M5G 2C4.
Wadea TarhuniDivision of Cardiology, University Hospital, Western University, London, Ontario, Canada N6G 2V4.
Sven ReischauerDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California 94158, USA.
Vijay S ChauhanDivision of Cardiology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada M5G 2C4.
Matthew BorkovichDivision of Cardiology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada M5G 2C4.
Shaheen UppalDivision of Cardiology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada M5G 2C4.
Arnon AdlerDivision of Cardiology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada M5G 2C4.
Shaun R CoughlinDepartment of Medicine, Cardiovascular Research Institute and Division of Cardiology, University of California San Francisco, San Francisco, California 94158, USA.
Didier Y R StainierDepartment of Medicine, Cardiovascular Research Institute and Division of Cardiology, University of California San Francisco, San Francisco, California 94158, USA.
Michael H GollobToronto General Research Institute, University Health Network, Toronto, Ontario, Canada M5G 2C4.
University Health Network · CAUniversity of California, San Francisco · USWestern University · CAToronto General Hospital · CAMax Planck Institute for Heart and Lung Research · DE

Funding

MOLECULAR GENETICS OF CARDIAC CELL DIFFERENTIATIONR01HL054737 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COUGHLIN, SHAUN R. · 1996 to 2015
$5.4M
Genetics and Structure of Trabecular Myocardium in Development and DiseaseK08HL125945 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARNAOUT, RIMA · 2015 to 2019
$863k
Genetic Analyst of Early Conduction System DevelopmentF32HL110489 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARNAOUT, RIMA · 2011 to 2012
$112k
Canadian Institutes of Health Research MOP130263NHLBI NIH HHS F32 HL110489NHLBI NIH HHS F32HL110489NHLBI NIH HHS HL54737NHLBI NIH HHS K08 HL125945NHLBI NIH HHS K08HL125945-01NHLBI NIH HHS R01 HL054737
6 · The paper itself

Abstract

Atrial fibrillation (AF), the most common arrhythmia, is a growing epidemic with substantial morbidity and economic burden. Mechanisms underlying vulnerability to AF remain poorly understood, which contributes to the current lack of highly effective therapies. Recognizing mechanistic subtypes of AF may guide an individualized approach to patient management. Here, we describe a family with a previously unreported syndrome characterized by early-onset AF (age <35 years), conduction disease and signs of a primary atrial myopathy. Phenotypic penetrance was complete in all mutation carriers, although complete disease expressivity appears to be age-dependent. We show that this syndrome is caused by a novel, heterozygous p.Glu11Lys mutation in the atrial-specific myosin light chain gene MYL4. In zebrafish, mutant MYL4 leads to disruption of sarcomeric structure, atrial enlargement and electrical abnormalities associated with human AF. These findings describe the cause of a rare subtype of AF due to a primary, atrial-specific sarcomeric defect.

Indexed as

AdultAnimalsAnimals, Genetically ModifiedAtrial FibrillationBinding SitesElectrocardiographyFemaleHeart AtriaHumansMaleMiddle AgedModels, MolecularMutant ProteinsMutationMyofibrilsMyosin Light ChainsMutant ProteinsMYL4 protein, humanMyosin Light Chains

Identifiers

PMID27066836
PMCPMC4832069
OpenAlexW2339307237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.